Clinical Trial Update: BMS-599626 in Patients With Advanced Solid Malignancies [Phase 1]

View source ↗

Summary

Phase 1 study of BMS-599626 in patients with advanced solid malignancies has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• BMS-599626

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Cancer, Metastases | Phase 1 | Status: COMPLETED